Home Latest Articles
Latest Articles
  • Yifan HUO, Suqin MAN, Jiachen XU, Tingting XU, Yunliang QIU
    Chinese Journal of Pharmaceuticals. 2024, 55(12): 1693-1697.

    Based on the principle that uricase catalyzes the decomposition of uric acid to produce allantoin, hydrogen peroxide and carbon dioxide, this paper established a method to detect the activity of uricase at 37 ℃ and pH 7.5. The results showed that the quantitative ranges of hydrogen peroxide and uricase were 0.049 - 100.000 μmol/L and 0.819 -200.000 mU/mL, respectively. The within- and between-run variation coefficients of precision were less than 20.0%, and the relative error of accuracy were within ±25.0%. The results of recovery experiments using hyperlipemia samples(lipid index 3 mg/mL) and 2% hemolysis donor samples compared to normal donor samples showed that hyperlipemia did not interfere with the detection of uricase activity, whereas hemolysis did. Uricase activity was not affected when human serum uricase samples were placed at room temperature or 2 - 8 ℃ for no more than 24 h, frozen and thawing for no more than 3 cycles, and stored at –70 –90 ℃ for no more than 64 days. In conclusion, the established method is sensitive, precise, accurate, simple, rapid, and can support the evaluation of preclinical and clinical studies of uricase drugs.

  • Xilong QU, Xiting WANG, Tiejian LI, Zhong FENG, Guimin ZHANG
    Chinese Journal of Pharmaceuticals. 2024, 55(12): 1698-1704.

    An ion-pair reversed phase high performance liquid chromatography method was established for the determination of the process impurities and degradation products in faropenem sodium(1). The Welch Xtimate C18 column(4.6 mm×150 mm, 3 μm) was used, and the analysis was carried out in the gradient elution mode with phosphate buffer(pH 3.0) as mobile phase A, and phosphate buffer-acetonitrile(50∶50) as mobile phase B. The flow rate was 1.0 mL/min, the column temperature was 25℃, and the injection volume was 20 μL. The results showed that the peaks of 1 and its related impurities were separated well, and it was linear for 1 and the related impurities in the corresponding ranges. The average recoveries(n=9) of the impurities were 96.35% - 104.28%, with the RSDs of 1.38% - 4.25%. The established method has high accuracy, sensitivity, specificity, and repeatability, which is suitable for the determination of process impurities and degradation products in 1.

  • Zhongli HAN, Honghua LU, Ting LI, Guizhou HAO, Guimin ZHANG
    Chinese Journal of Pharmaceuticals. 2024, 55(12): 1705-1707.

    A gas chromatography-mass spectrometry(GC-MS) method was established for two genotoxic alkyl chloride impurities, namely 4-chloro-4-methylpentan-2-one(2) and 2,6-dichloro-2,6-dimethyl-4-heptanone(3), in cetirizine dihydrochloride(1). The VF-WAXms capillary column(0.25 mm×30 m×0.25 μm) was used, and the measurement was performed in selected ion monitoring(SIM) mode. The results showed that it was linear for 2 and 3 in the ranges of 75.86 -455.16 ng/mL and 75.18 - 451.08 ng/mL. The limits of quantification were 0.025 and 0.066 ng/mL, respectively. Tthe recoveries were 101.66% and 102.46%, respectively. The established method can determine 2 and 3 in 1, which provide a reference for the quality study of 1.

  • Xiaohong ZANG, Jingjing YAO, Jingmei LI
    Chinese Journal of Pharmaceuticals. 2024, 55(12): 1708-1712.

    An ICP-MS method was established for the determination of elemental impurities, namely Cd, Pb, As, Hg, Co, V, Ni, Li, Sb, Cu in tert-butanol. The microwave digestion method was used, and the sample was digested with a nitric acid-hydrochloric acid mixed solution. After eliminating matrix interference and instrument drift through online internal standards, the measurement was carried out. The results showed that the quantification limits of Cd, Pb, As, Hg, Co, V, Ni, Li, Sb, and Cu were 0.028 8, 0.179 8, 0.057 6, 0.229 4, 0.015 3, 0.025 3, 0.232 2, 1.226 0, 0.021 9, and 0.138 6 ng/mL, respectively, all of which were less than 5% of the limit values and met the detection requirements. The RSDs of repeatability and precision were both less than 20%. Within 25% to 300% of the limit concentration range, it was linear for the ten elemental impurities, with recovery rates ranging from 90% to 120%. The established ICP-MS method is convenient, fast, highly sensitive, and accurate, which provide a technical support for the quality control research of tert-butanol.

  • Cuiping HUANG, Yuqing WANG, Na ZHANG, Yujie ZHANG, Qianying LIU
    Chinese Journal of Pharmaceuticals. 2024, 55(12): 1713-1717.
  • Yimeng ZHANG, Yuejiao CHEN, Huitong YANG, Shuzhen CHU
    Chinese Journal of Pharmaceuticals. 2024, 55(12): 1718-1722.
  • Jiaqi ZHOU, Hong SU, Xuewei HUA, Li’e LI, Wen GUO, Fener CHEN
    Chinese Journal of Pharmaceuticals. 2024, 55(12): 1723-1727.
  • Jianyi LI, Hancheng WANG, Han ZHANG, Xingyu WU, Qiushi CHEN, Qingwei ZHANG
    Chinese Journal of Pharmaceuticals. 2024, 55(11): 1449-1466.

    Deuterium substitution is a method that involves replacing specific hydrogen(H) atoms in drug molecules with deuterium(D) atoms, thereby improving the absorption, distribution, metabolism, and affecting of the drug molecules within the body. It can reduce the dosage or frequency of administration, enhance safety, and achieve better therapeutic outcomes. Nowadays, deuterium substitution has become an important strategy in rational drug design and optimization of druggability. The methods of deuterated modification primarily include chemical synthesis and enzymatic catalysis. Chemical synthesis encompasses techniques such as the introduction of deuterated intermediates, halogen or unsaturated bond reduction, acid/base catalysis, and metal-catalyzed hydrogen-deuterium exchange. Enzymatic catalysis involves methods such as enzyme-catalyzed hydrogen-deuterium exchange, reductive deuteration, and decarboxylative deuteration. This review outlines the latest research progress of drug molecule deuteration in recent years with the aim of providing references for the research and development of deuterated drugs.

  • Hengyuan MA, Zhiqiang KE, Zhengding SU
    Chinese Journal of Pharmaceuticals. 2024, 55(11): 1467-1476.

    Traditional small molecule kinase inhibitor drugs face numerous challenges, such as the propensity for drug resistance and the problem that some targets are undruggable. The proteolysis targeting chimera(PROTAC) technology utilizes the inherent ubiquitin-proteasome system in cells to achieve the degradation of proteins of interest(POI) for treating diseases, which can avoid the limitations of undruggable targets and drug resistance. Therefore, the PROTAC technology is expected to overcome the limitations of small molecule inhibitors. At present, some PROTACs have entered the clinical trial stage and are expected to become potential treatment methods for many diseases. This review introduces the biological mechanism, technical advantages, molecular design and clinical application prospects of PROTAC, hoping to provide a reference for its drug development and clinical application.

  • Jifang LIU, Xuhua LIANG, Lingyan KONG, Min CHENG, Aigen FU
    Chinese Journal of Pharmaceuticals. 2024, 55(11): 1477-1484.

    Covalent organic frameworks(COFs) have attracted great attention in the field of drug delivery due to their characteristics such as high specific surface area, uniform and adjustable pore size, and facile modification and functionalization. This review introduces the preparation methods of COFs, including template-mediated coprecipitation method, one-pot synthesis method and in situ doping method. More over, this review elaborates the structural design of COFs, including intelligent stimuli-responsive molecular design and surface modification. In addition, this review also outlines the applications of COFs in the field of delivery of antineoplastic, antibacterial and anti-inflammatory drugs, aiming to provide insightful perspectives to facilitate the rapid development of COFs-based drug delivery systems.

News